Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
163 hedge funds and large institutions have $368M invested in Meridian Bioscience Inc in 2019 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 61 increasing their positions, 56 reducing their positions, and 27 closing their positions.
9% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 56
6% less funds holding
Funds holding: 173 → 163 (-10)
20% less capital invested
Capital invested by funds: $462M → $368M (-$94M)
33% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$4.9M |
| 2 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$3.46M |
| 3 |
Renaissance Technologies
New York
|
+$3.38M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$1.81M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$11.9M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$3.99M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$3.92M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.77M |
VIVO Hedge Fund Activity: Q3 2019 in Review
163 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2019, worth a combined $368M — down 20% from $462M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of VIVO and 18 opened new positions — a net loss of 9 holders — while 56 trimmed existing stakes and 61 added.
The largest buyer was JP Morgan Chase, adding an estimated $4.9M. The largest seller was Brown Capital Management, cutting an estimated $11.9M.
- 163 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2019, down from 173 in Q2 2019.
- Funds reported $368M of Meridian Bioscience Inc stock for Q3 2019, down 20% quarter-over-quarter.
- 18 funds opened new Meridian Bioscience Inc positions in Q3 2019 and 27 closed out, a net change of -9 holders.
- The largest Meridian Bioscience Inc buyer in Q3 2019 was JP Morgan Chase, an estimated $4.9M added.
- The largest Meridian Bioscience Inc seller in Q3 2019 was Brown Capital Management, an estimated $11.9M sold.
Based on aggregated 13F filings for Q3 2019.